4//SEC Filing
TETRAPHASE PHARMACEUTICALS INC 4
Accession 0001209191-14-008365
CIK 0001373707operating
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:13 PM ET
Size
4.6 KB
Accession
0001209191-14-008365
Insider Transaction Report
Form 4
Sutcliffe Joyce A.
Senior Vice President, Biology
Transactions
- Sale
Common Stock
2014-02-05$13.93/sh−11,494$160,111→ 40,230 total
Documents
Issuer
TETRAPHASE PHARMACEUTICALS INC
CIK 0001373707
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001373707
Filing Metadata
- Form type
- 4
- Filed
- Feb 6, 7:00 PM ET
- Accepted
- Feb 7, 4:13 PM ET
- Size
- 4.6 KB